Latest / Durham News Today | 2 Min News | The Daily News Now!
Merck’s Melanoma Vaccine Breakthrough | Durham News
Merck and Moderna just unveiled a game-changing breakthrough in melanoma treatment: a personalized mRNA cancer vaccine, V940, that works powerfully alongside Merck’s blockbuster drug Keytruda. In a landmark late-stage trial, patients receiving the combo stayed cancer-free longer and saw less spread than those on Keytruda alone—marking the first time an individualized vaccine has shown such promise in a large-scale study. The science is revolutionary: each patient’s tumor is sequenced, then used to craft a custom mRNA shot that trains their immune system to target unique cancer mutations. For…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.